Omalizumab

General description This gene belongs to the homeobox family, members of which encode a highly conserved family of transcription factors that play an important role in morphogenesis in all multicellular organisms. Mammals possess four similar

General description This gene belongs to the homeobox family, members of which encode a highly conserved family of transcription factors that play an important role in morphogenesis in all multicellular organisms. Mammals possess four similar

General description This gene belongs to the homeobox family, members of which encode a highly conserved family of transcription factors that play an important role in morphogenesis in all multicellular organisms. Mammals possess four similar

General description This gene belongs to the homeobox family, members of which encode a highly conserved family of transcription factors that play an important role in morphogenesis in all multicellular organisms. Mammals possess four similar

General description This gene is a member of the Antp homeobox family and encodes a protein with a homeobox DNA-binding domain. This nuclear protein functions as a sequence-specific transcription factor that is involved in differentiation and limb

HOXD11 is a homeobox transcription factor that regulates morphogenesis. It is known to modulate metanephric kidney development in mouse embryos .

Anti-Llama IgG(H+L)APC,(Poly,Rabbit IgG)1mg

Anti-Llama IgG(H+L)Biotin,(Poly,Rabbit IgG)1mg

Homeobox protein Nkx-6.1 (UniProt: P78426 also known as Homeobox protein NK-6 homolog A) is encoded by the NKX6-1 (also known as NKX6A) gene (gene ID: 4825) in human.

OAZ1 (ornithine decarboxylase antizyme 1) is simply known as AZ1. AZ was first recognized in mammals, and is present in multiple isoforms namely, AZ1, AZ2, AZ3 and AZ4.

Immunogen Synthetic peptide directed towards the middle region of human OMA1 Biochem/physiol Actions OMA1 is a mitochondrial protease. Sequence Synthetic peptide located within the following region:

Omalizumab with trade name Xolair, is an FDA-approved drug for the treatment of moderate to severe persistent asthma in adults and adolescents (12 years of age and above). It is a recombinant humanized monoclonal antibody.